Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been ...

Catholic Cemeteries of the Diocese of Tucson has announced a program that will entomb the cremains of loved ones for families who are too financially strapped to pay for the service. Bishop Gerald F.

I believe that Merck (NYSE:MRK) is a good long-term pharmaceutical company to own and with that being said, it is because of several excellent moves it has made in the last few years. The first major ...

SEATTLE — If this was it for Clayton Kershaw, his 3,052nd and final strikeout came on his calling card, a day on which he once again was brilliant. His final regular-season start was like several of ...

Cleveland – Charlie Morton walked off the field at Comerica Park last Friday to a spattering of boos, given the early hook after being tagged for six runs in 1.1 innings. He was released by the Tigers ...

The U.S. Food and Drug Administration (FDA) on Friday approved Merck & Co. Inc.’s (NYSE:MRK) Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) injection for subcutaneous administration in ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a subcutaneous induction regimen of guselkumab for the treatment of adults with moderately ...

Merck's Keytruda Qlex offers a groundbreaking subcutaneous cancer treatment, enhancing patient convenience with faster administration and broader access to immunotherapy. The FDA approved Merck’s ...

The FDA has approved Merck & Co.’s under-the-skin version of Keytruda, reducing treatment time burden for patients while granting the world’s bestselling drug potential blockbuster revenue protection.